Company profile: BioMedion
1.1 - Company Overview
Company description
- Provider of compliance management software and services for the highly regulated life science industry, medicines agencies, and national competent authorities. Offers GxP quality, compliance, and archiving solutions, including neuronOS, IMAGE+, WATCH+, regulatory operations services, raw data archiving, and subject-matter expertise, computer system validation, and training management.
Products and services
- NeuronOS: A GxP-compliant platform that manages complex data workflows with minimal manual intervention, supports multiple data formats, and ensures compliance through audit trails and metadata management
- WATCH+: A regulatory-compliant system that automates transfer and enrichment of raw data from on‑premise systems to archives, ensuring data integrity and compliance with regulatory standards
- Raw Data Archiving: An archival‑grade product delivering secure storage and access of raw data, ensuring compliance with data integrity guidelines and providing long‑term data protection
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioMedion
Cromsource
HQ: Italy
Website
- Description: Provider of clinical life sciences services focused on the clinical development of medicines and medical devices, offering a comprehensive range of clinical research services and expert staffing solutions for pharma, biotech, vaccine, and medical device companies. Independent and international.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cromsource company profile →
Central Research Associates
HQ: United States
Website
- Description: Provider of multi-specialty clinical services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Central Research Associates company profile →
Acurian
HQ: United States
Website
- Description: Provider of patient and doctor recruitment, enrollment and retention solutions for clinical trials, including recruitment feasibility, site identification and selection, data-driven patient recruitment, an integrated network for AES research sites, geo-targeted vaccine volunteer enrollment via a global site network, specialized strategies for challenging indications (Alzheimer's, NASH), and cancer solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acurian company profile →
Capacity Bio
HQ: United States
Website
- Description: Provider of mitophagy-focused therapeutics and a development platform to restore mitochondrial quality control in disease. Offers mitophagy agonists (small molecules, peptides, nanoparticles) to enhance removal of dysfunctional mitochondria; mitochondrial modulators in preclinical programs for mitochondrial dysfunction across various diseases; and a mitophagy therapeutic platform to induce mitochondrial turnover and improve mitochondrial performance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Capacity Bio company profile →
Biosynth
HQ: Switzerland
Website
- Description: Provider of critical raw materials and services to the pharmaceutical and diagnostics industries, offering custom synthesis and manufacturing services. Focused on consolidating the fragmented supply chain to improve availability and reduce time-to-market for new therapies and diagnostic assays, increasing industry productivity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biosynth company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioMedion
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioMedion
2.2 - Growth funds investing in similar companies to BioMedion
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioMedion
4.2 - Public trading comparable groups for BioMedion
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →